145 related articles for article (PubMed ID: 20500075)
21. Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.
Lazebnik MB; Tussie-Luna MI; Hinds PW; Roy AL
J Biol Chem; 2009 Dec; 284(52):36234-36239. PubMed ID: 19880526
[TBL] [Abstract][Full Text] [Related]
22. The early embryonic expression of TFII-I during mouse preimplantation development.
Enkhmandakh B; Bitchevaia N; Ruddle F; Bayarsaihan D
Gene Expr Patterns; 2004 Jan; 4(1):25-8. PubMed ID: 14678824
[TBL] [Abstract][Full Text] [Related]
23. GTF2IRD1 in craniofacial development of humans and mice.
Tassabehji M; Hammond P; Karmiloff-Smith A; Thompson P; Thorgeirsson SS; Durkin ME; Popescu NC; Hutton T; Metcalfe K; Rucka A; Stewart H; Read AP; Maconochie M; Donnai D
Science; 2005 Nov; 310(5751):1184-7. PubMed ID: 16293761
[TBL] [Abstract][Full Text] [Related]
24. GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.
Palmer SJ; Taylor KM; Santucci N; Widagdo J; Chan YK; Yeo JL; Adams M; Gunning PW; Hardeman EC
J Cell Sci; 2012 Nov; 125(Pt 21):5040-50. PubMed ID: 22899722
[TBL] [Abstract][Full Text] [Related]
25. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.
Howard ML; Palmer SJ; Taylor KM; Arthurson GJ; Spitzer MW; Du X; Pang TY; Renoir T; Hardeman EC; Hannan AJ
Neurobiol Dis; 2012 Mar; 45(3):913-22. PubMed ID: 22198572
[TBL] [Abstract][Full Text] [Related]
26. Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23.
Hirota H; Matsuoka R; Chen XN; Salandanan LS; Lincoln A; Rose FE; Sunahara M; Osawa M; Bellugi U; Korenberg JR
Genet Med; 2003; 5(4):311-21. PubMed ID: 12865760
[TBL] [Abstract][Full Text] [Related]
27. Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.
Makeyev AV; Enkhmandakh B; Hong SH; Joshi P; Shin DG; Bayarsaihan D
PLoS One; 2012; 7(9):e44443. PubMed ID: 22970219
[TBL] [Abstract][Full Text] [Related]
28. Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren syndrome.
Lazebnik MB; Tussie-Luna MI; Roy AL
J Biol Chem; 2008 Apr; 283(17):11078-82. PubMed ID: 18326499
[TBL] [Abstract][Full Text] [Related]
29. Expression of Gtf2ird1, the Williams syndrome-associated gene, during mouse development.
Palmer SJ; Tay ES; Santucci N; Cuc Bach TT; Hook J; Lemckert FA; Jamieson RV; Gunnning PW; Hardeman EC
Gene Expr Patterns; 2007 Feb; 7(4):396-404. PubMed ID: 17239664
[TBL] [Abstract][Full Text] [Related]
30. Alternative splicing and promoter use in TFII-I genes.
Makeyev AV; Bayarsaihan D
Gene; 2009 Mar; 433(1-2):16-25. PubMed ID: 19111598
[TBL] [Abstract][Full Text] [Related]
31. The role of GTF2IRD1 in the auditory pathology of Williams-Beuren Syndrome.
Canales CP; Wong AC; Gunning PW; Housley GD; Hardeman EC; Palmer SJ
Eur J Hum Genet; 2015 Jun; 23(6):774-80. PubMed ID: 25248400
[TBL] [Abstract][Full Text] [Related]
32. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
33. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
34. Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.
Schneider T; Skitt Z; Liu Y; Deacon RM; Flint J; Karmiloff-Smith A; Rawlins JN; Tassabehji M
Behav Brain Res; 2012 Aug; 233(2):458-73. PubMed ID: 22652393
[TBL] [Abstract][Full Text] [Related]
35. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
36. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
[TBL] [Abstract][Full Text] [Related]
37. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
38. Exome sequencing of 85 Williams-Beuren syndrome cases rules out coding variation as a major contributor to remaining variance in social behavior.
Kopp ND; Parrish PCR; Lugo M; Dougherty JD; Kozel BA
Mol Genet Genomic Med; 2018 Sep; 6(5):749-765. PubMed ID: 30008175
[TBL] [Abstract][Full Text] [Related]
39. TFII-I, a candidate gene for Williams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype.
Danoff SK; Taylor HE; Blackshaw S; Desiderio S
Neuroscience; 2004; 123(4):931-8. PubMed ID: 14751286
[TBL] [Abstract][Full Text] [Related]
40. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
